{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T04:40:09Z","timestamp":1709008809024},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2008,6,13]],"date-time":"2008-06-13T00:00:00Z","timestamp":1213315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s00415-008-0856-0","type":"journal-article","created":{"date-parts":[[2008,6,5]],"date-time":"2008-06-05T18:57:33Z","timestamp":1212692253000},"page":"1259-1260","source":"Crossref","is-referenced-by-count":2,"title":["The potential use of ephedrine in Lambert-Eaton myasthenic syndrome"],"prefix":"10.1007","volume":"255","author":[{"given":"C.","family":"Cereda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kuntzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,13]]},"reference":[{"key":"856_CR1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pcad.2004.07.006","volume":"47","author":"Andraws","year":"2005","unstructured":"Andraws R, Chawla P, Brown DL (2005) Cardiovascular effects of ephedra alkaloids: a comprehensive review. Prog Cardiovasc Dis 47:217\u2013225","journal-title":"Prog Cardiovasc Dis"},{"key":"856_CR2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1212\/01.wnl.0000167132.35865.31","volume":"65","author":"Bestue-Cardiel","year":"2005","unstructured":"Bestue-Cardiel M, S\u00e1enz de Cabez\u00f3n-Alvarez A, Capablo-Liesa JL, et al. (2005) Congenital endplate acetylcholinesterase deficiency responsive to ephedrine. Neurology 65:144\u2013146","journal-title":"Neurology"},{"key":"856_CR3","first-page":"799","volume":"19","author":"Felice","year":"1996","unstructured":"Felice KJ, Relva GM (1996) Ephedrine in the treatment of congenital myasthenic syndrome. Muscle Nerve 19:799\u2013800","journal-title":"Muscle Nerve"},{"key":"856_CR4","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.clinph.2004.01.004","volume":"115","author":"Kuntzer","year":"2004","unstructured":"Kuntzer T, Michel P (2004) Muscle membrane polarisation after provocative tests, and after cooling: the normal CMAP changes to be expected. Clin Neurophysiol 115:1457\u20131463","journal-title":"Clin Neurophysiol"},{"key":"856_CR5","doi-asserted-by":"crossref","unstructured":"Maddison P, Newsom-Davis J (2005) Treatment for Lambert-Eaton myasthenic syndrome. Cochrane Database Syst Rev CD003279","DOI":"10.1002\/14651858.CD003279.pub2"},{"key":"856_CR6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0006-8993(96)00894-3","volume":"740","author":"Milone","year":"1996","unstructured":"Milone M, Engel AG (1996) Block of the endplate acetylcholine receptor channel by the sympathomimetic agents ephedrine, pseudoephedrine, and albuterol. Brain Res 740:346\u2013352","journal-title":"Brain Res"},{"key":"856_CR7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0028-3908(93)90159-Z","volume":"32","author":"Molenaar","year":"1993","unstructured":"Molenaar PC, Biewenga JE, Van Kempen GT, et al. (1993) Effect of ephedrine on muscle weakness in a model of myasthenia gravis in rats. Neuropharmacology 32:373\u2013376","journal-title":"Neuropharmacology"},{"key":"856_CR8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/mus.880010304","volume":"1","author":"Patten","year":"1978","unstructured":"Patten BM (1978) Myasthenia gravis: review of diagnosis and management. Muscle Nerve 1:190\u2013205","journal-title":"Muscle Nerve"},{"key":"856_CR9","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/jama.289.12.1537","volume":"289","author":"Shekelle","year":"2003","unstructured":"Shekelle PG, Hardy ML, Morton SC, et al. (2003). Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a metaanalysis. JAMA 289:1537\u20131545","journal-title":"JAMA"},{"key":"856_CR10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0006-8993(93)90025-I","volume":"623","author":"Sieb","year":"1993","unstructured":"Sieb JP, Engel AG (1993) Ephedrine: effects on neuromuscular transmission. Brain Res 623:167\u2013171","journal-title":"Brain Res"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-008-0856-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-008-0856-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-008-0856-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T04:01:01Z","timestamp":1709006461000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-008-0856-0"}},"subtitle":["Clinical and electrophysiological evaluation"],"short-title":[],"issued":{"date-parts":[[2008,6,13]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["856"],"URL":"https:\/\/doi.org\/10.1007\/s00415-008-0856-0","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,13]]}}}